A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis

被引：0
|
作者：
Christopher J. Edwards
Ruta Sawant
Vishvas Garg
Ella X. Du
Alan Friedman
Keith A. Betts
机构：
[1] University Hospital Southampton NHS Foundation Trust,NIHR Clinical Research Facility
[2] AbbVie,undefined
[3] Inc.,undefined
[4] Analysis Group,undefined
[5] Inc.,undefined
来源：
Rheumatology and Therapy | 2021年 / 8卷
关键词：
Combination therapy; Efficacy; Matching-adjusted indirect comparison; Monotherapy; Rheumatoid arthritis; Tofacitinib; Upadacitinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：167 / 181
页数：14
相关论文
共 50 条
  • [1] A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis
    Edwards, Christopher J.
    Sawant, Ruta
    Garg, Vishvas
    Du, Ella X.
    Friedman, Alan
    Betts, Keith A.
    [J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 167 - 181
  • [2] A MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF UPADACITINIB VERSUS TOFACITINIB IN CSDMARD-IR PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS (RA)
    Edwards, Christopher
    Sawant, Ruta
    Du, Ella
    Cammarota, Jordan
    Tang, Patrick
    Garg, Vishvas
    Friedman, Alan
    Betts, Keith
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 358 - 358
  • [3] A MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF UPADACITINIB VERSUS TOFACITINIB IN CSDMARD-IR PATIENTS WITH MODERATE TO SEVERE RA
    Edwards, Christopher
    Sawant, Ruta
    Du, Ella X.
    Cammarota, Jordan
    Tang, Patrick
    Garg, Vishvas
    Friedman, Alan
    Betts, Keith
    [J]. RHEUMATOLOGY, 2020, 59 : 104 - 104
  • [4] MATCHING ADJUSTED INDIRECT COMPARISON OF FILGOTINIB VS. TOFACITINIB IN MODERATE-TO-SEVERE ACTIVE RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE
    Gharaibeh, M.
    Smith, N.
    Jeyakumar, S.
    Mark, E.
    Shreay, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1005 - 1006
  • [5] Matching-adjusted indirect treatment comparison of guselkumab and ixekizumab in patients with moderate-to-severe psoriasis
    Varu, Abhishek
    Cameron, Chris
    Diels, Joris
    Hutton, Brian
    McElligott, Sean
    Schubert, Agata
    van Sanden, Suzy
    Villacorta, Reggie
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB187 - AB187
  • [6] COMPARATIVE EFFICACY OF GUSELKUMAB AND TILDRAKIZUMAB IN MODERATE-TO-SEVERE PLAQUE PSORIASIS: A MATCHING-ADJUSTED INDIRECT COMPARISON
    Van, Sanden S.
    Diels, J.
    Schubert, A.
    Barthelmes, J.
    [J]. VALUE IN HEALTH, 2020, 23 : S410 - S410
  • [7] MATCHING-ADJUSTED INDIRECT COMPARISON OF IXEKIZUMAB VS. TOFACITINIB IN PSORIATIC ARTHRITIS
    Sapin, C.
    Panni, T.
    Meszaros, G.
    Hill, J.
    Hartz, S.
    [J]. VALUE IN HEALTH, 2020, 23 : S593 - S593
  • [8] Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
    Torres, Tiago
    Petersen, Anne Sohrt
    Ivens, Ulla
    Vilaro, Albert Bosch
    Stinson, John
    Carrascosa, Jose Manuel
    [J]. DERMATOLOGY AND THERAPY, 2024, 14 (04) : 983 - 992
  • [9] A MATCHING-ADJUSTED INDIRECT COMPARISON OF FILGOTINIB VERSUS TOFACITINIB FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Lu, X.
    Gray, E.
    Xin, Y.
    Zhou, J.
    Jairath, V
    Lindsay, J. O.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S321 - S321
  • [10] Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab
    Warren, R. B.
    Brnabic, A.
    Saure, D.
    Langley, R. G.
    See, K.
    Wu, J. J.
    Schacht, A.
    Mallbris, L.
    Nast, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (05) : 1064 - 1071
12345